Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci  H.L. DuPont, Z.-D. Jiang  Clinical Microbiology.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Rapid streptococcal testing for sore throat and antibiotic resistance
J.-C. Lagier  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz 
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
Clinical Microbiology and Infection
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Postoperative urinary tract infection and surgical site infection in instrumented spinal surgery: is there a link?  S. Núñez-Pereira, D. Rodríguez-Pardo,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
E. Lindberg, I. Adlerberth, A.E. Wold 
R. Cantón  Clinical Microbiology and Infection 
Rapid streptococcal testing for sore throat and antibiotic resistance
Louis Pasteur, from crystals of life to vaccination
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
J. Cairo, R. Hachem, G. Rangaraj, B. Granwehr, I. Raad 
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul 
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic  A.S.
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
Clinical Microbiology and Infection
H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi 
Vector control: a cornerstone in the malaria elimination campaign
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
Characterization of Mycobacterium tuberculosis isolated from cancer patients with suspected tuberculosis infection in Egypt: identification, prevalence,
Training for the infectious diseases speciality in Norway
G. Höffken  Clinical Microbiology and Infection 
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.
L. Zhang, Q. Meng, S. Chen, M. Zhang, B. Chen, B. Wu, G. Yan, X
Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community  R.E. Warren, G. Harvey, R. Carr, D. Ward,
Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan  P.-R. Hsueh, J.-M. Shyr, J.-J. Wu  Clinical.
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Selection of rifampicin-resistant Mycobacterium tuberculosis does not occur in the presence of low concentrations of rifaximin  Ornella Soro, Adelaide.
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin  King A. , Bathgate.
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Update on antifungal resistance in Aspergillus and Candida
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
The role of antimalarial treatment in the elimination of malaria
Abstracts cont. Clinical Microbiology and Infection
A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures  A. Makristathis, S. Riss, A.M. Hirschl 
Current experience in treating invasive zygomycosis with posaconazole
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria  E. Presterl, F. Daxböck, W. Graninger,
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
C. Novais, T.M. Coque, J.C. Sousa, L.V. Peixe 
Abstracts Clinical Microbiology and Infection
Serum ferritin levels in West Nile encephalitis
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci  V. Sakka, S. Tsiodras, L. Galani, A. Antoniadou,
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
New patterns of HIV-1 resistance during HAART
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci  H.L. DuPont, Z.-D. Jiang  Clinical Microbiology and Infection  Volume 10, Issue 11, Pages 1009-1011 (November 2004) DOI: 10.1111/j.1469-0691.2004.00997.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Numbers of faecal rifaximin- and rifampicin-resistant coliforms (GNB) isolated pre-treatment (day 0), immediately post-treatment (day 3) and 2 days post-treatment (day 5) from patients treated for 3 days with either rifaximin 1200 mg/day, rifaximin 600 mg/day or placebo. Clinical Microbiology and Infection 2004 10, 1009-1011DOI: (10.1111/j.1469-0691.2004.00997.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.